These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 27210466)
1. Cortisol Excess and the Brain. Resmini E; Santos A; Webb SM Front Horm Res; 2016; 46():74-86. PubMed ID: 27210466 [TBL] [Abstract][Full Text] [Related]
2. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies. Andela CD; van Haalen FM; Ragnarsson O; Papakokkinou E; Johannsson G; Santos A; Webb SM; Biermasz NR; van der Wee NJ; Pereira AM Eur J Endocrinol; 2015 Jul; 173(1):R1-14. PubMed ID: 25650405 [TBL] [Abstract][Full Text] [Related]
3. Psychiatric and neurocognitive consequences of endogenous hypercortisolism. Piasecka M; Papakokkinou E; Valassi E; Santos A; Webb SM; de Vries F; Pereira AM; Ragnarsson O J Intern Med; 2020 Aug; 288(2):168-182. PubMed ID: 32181937 [TBL] [Abstract][Full Text] [Related]
4. Neuropsychological Functioning in Patients with Cushing's Disease and Cushing's Syndrome. Siegel S; Kirstein CF; Grzywotz A; Hütter BO; Wrede KH; Kuhna V; Kreitschmann-Andermahr I Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):194-202. PubMed ID: 32992348 [TBL] [Abstract][Full Text] [Related]
5. Morbidity of Cushing's Syndrome and Impact of Treatment. Webb SM; Valassi E Endocrinol Metab Clin North Am; 2018 Jun; 47(2):299-311. PubMed ID: 29754633 [TBL] [Abstract][Full Text] [Related]
6. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome. Forget H; Lacroix A; Bourdeau I; Cohen H Psychoneuroendocrinology; 2016 Mar; 65():26-33. PubMed ID: 26708069 [TBL] [Abstract][Full Text] [Related]
7. Cognitive function and cerebral assessment in patients who have Cushing's syndrome. Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847 [TBL] [Abstract][Full Text] [Related]
8. A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. León-Carrión J; Atutxa AM; Mangas MA; Soto-Moreno A; Pumar A; Leon-Justel A; Martín-Rodriguez JF; Venegas E; Domínguez-Morales MR; Leal-Cerro A Clin Endocrinol (Oxf); 2009 Feb; 70(2):192-200. PubMed ID: 18702680 [TBL] [Abstract][Full Text] [Related]
9. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. Bourdeau I; Bard C; Noël B; Leclerc I; Cordeau MP; Bélair M; Lesage J; Lafontaine L; Lacroix A J Clin Endocrinol Metab; 2002 May; 87(5):1949-54. PubMed ID: 11994323 [TBL] [Abstract][Full Text] [Related]
10. Functional brain alterations in Cushing's syndrome. Papakokkinou E; Ragnarsson O Front Endocrinol (Lausanne); 2023; 14():1163482. PubMed ID: 37152946 [TBL] [Abstract][Full Text] [Related]
15. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. Dorn LD; Burgess ES; Friedman TC; Dubbert B; Gold PW; Chrousos GP J Clin Endocrinol Metab; 1997 Mar; 82(3):912-9. PubMed ID: 9062506 [TBL] [Abstract][Full Text] [Related]
16. Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess. Pivonello R; De Martino MC; Iacuaniello D; Simeoli C; Muscogiuri G; Carlomagno F; De Leo M; Cozzolino A; Colao A Front Horm Res; 2016; 46():54-65. PubMed ID: 27212264 [TBL] [Abstract][Full Text] [Related]
17. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179 [TBL] [Abstract][Full Text] [Related]
18. Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Wagenmakers MA; Netea-Maier RT; Prins JB; Dekkers T; den Heijer M; Hermus AR Eur J Endocrinol; 2012 Nov; 167(5):687-95. PubMed ID: 22936421 [TBL] [Abstract][Full Text] [Related]
19. Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome. Crespo I; Esther GM; Santos A; Valassi E; Yolanda VG; De Juan-Delago M; Webb SM; Gómez-Ansón B; Resmini E Clin Endocrinol (Oxf); 2014 Dec; 81(6):826-33. PubMed ID: 25052342 [TBL] [Abstract][Full Text] [Related]
20. Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy. Resmini E; Santos A; Gómez-Anson B; López-Mourelo O; Pires P; Vives-Gilabert Y; Crespo I; Portella MJ; de Juan-Delago M; Webb SM Clin Endocrinol (Oxf); 2013 Nov; 79(5):700-7. PubMed ID: 23594250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]